Related Experiment Video
Updated: Aug 10, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Follicular thyroid cancer presenting initially with soft tissue metastasis
A Sevinc1, S Buyukberber, R Sari
1Department of Internal Medicine, School of Medicine, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey.
Japanese Journal of Clinical Oncology
|April 19, 2000
Summary
Follicular thyroid cancer can present unusually with distant soft tissue metastasis. This case highlights a rare initial presentation and subsequent widespread disease progression.
Area of Science:
- Oncology
- Endocrinology
Background:
- Follicular thyroid carcinoma (FTC) typically presents as a localized thyroid malignancy.
- Distant metastasis at initial diagnosis is uncommon for FTC.
Observation:
- A 58-year-old woman presented with an asymptomatic soft tissue mass, later diagnosed as metastatic FTC.
- Initial evaluation revealed a thyroid nodule consistent with follicular neoplasm.
- The patient initially refused treatment, leading to disease progression.
Findings:
- The patient developed extensive, sarcoma-like soft tissue masses over 2.5 years.
- Elevated serum thyroglobulin levels (3500 ng/ml) indicated advanced disease.
- Chemotherapy with epirubicin and cyclophosphamide resulted in stable disease.
Implications:
- This case underscores the importance of considering rare metastatic presentations of FTC.
- Delayed treatment can lead to significant disease progression and widespread metastasis.
- Chemotherapy may be a viable option for managing advanced, metastatic FTC.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

